Open-label, single-arm, multiple-dose safety, titration, and pharmacokinetic study of AFREZZA® in pediatric subjects ages 4 to 17 years with type 1 diabetes mellitus

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: type 1 diabetes mellitus
  • Age: Between 4 - 12 Years
  • Gender: Male or Female

Inclusion Criteria

Diagnosed with Type 1 diabetes for at least 1 year

Currently on multiple daily injections

No history of asthma

Recruitment Status


Contact the research team to learn more about this study.

Fields marked with asterisk (*) are required

Please verify that you are not a bot.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Volunteer Sign up

Volunteer Registry

Create your profile and be matched to research opportunities

Register Now!

Contact Us

If you need help finding a study or have any questions, please contact us at or by phone at (888) 264-0005.